Boswellia Serrata Supplement Manufacturer

The first decision that protects your budget is material type – not a generic “Boswellia extract” line item.

“Boswellia extract” is not a complete specification. Botanical identity, plant part, extract type, marker (TBA or AKBA), assay method, and serving math have to be agreed before sampling. Until those fields are locked, a low $/kg quote is not a saving; it is a different product.

A 10:1 ratio does not mean 10x TBA or AKBA potency. Ratio and marker standardization describe different properties of the extract. If your brief needs a quantified marker, lock TBA or AKBA and the method – do not treat the ratio as the potency.

Do not compare quotes by $/kg of unmatched grades. A ratio extract and a TBA-standardized extract are different commercial materials. If your label will state TBA or AKBA, resin powder and unmarked ratio grades will not support that claim without a different specification, extra testing, and batch-to-batch variability you have not priced.

What to ask every supplier: Do not compare “mg of extract per serving” alone. Ask for the standardization target and the analytical method. TBA may be reported by HPLC or a validated titration method, depending on the specification. AKBA, when specified, is quantified by an HPLC-based method written into the file. Method and marker change your real cost per active unit and what the label can defensibly support.

Do not treat B. serrata, B. sacra, and B. carterii as interchangeable raw materials. Confirm the botanical species on the incoming specification and lock B. serrata oleogum resin as the source.

Standardized botanical pathways: Standard Extracts. For finished-product development, see our supplement contract manufacturing service.

Once you choose a material type, lock the fields that control identity, potency math, process behavior, and the label. A short, complete spec gets you a usable first quote and saves a reformulation after sampling.

The fields that change your price and label

If a brief only says “Boswellia extract 65%,” ask whether that is TBA or something else – and which method is on the COA. Two TBA results are not interchangeable if the methods differ. You cannot treat them as the same PO line.

TBA refers to total boswellic acids as defined by the agreed analytical specification; it should not be treated as equivalent to a single boswellic acid such as AKBA.

A 500 mg Boswellia extract serving does not tell you how much TBA or AKBA the formula delivers. Calculate the declared marker from the actual assay and serving size. For illustration only: 500 mg extract x 65% TBA = 325 mg TBA. That is serving math against a named assay – not a dosage recommendation and not a default grade.

Fields that can wait until the market file is known

Do not let these block your first quote. They are confirmed against the destination market and packaging brief:

• Organic certification, when the SKU requires it
• Non-GMO statement, when the SKU requires it
• Allergen statement
• Country of origin as declared on the project file
• Halal / Kosher documentation for the selling market

How to read a Boswellia COA before you sample

A useful Certificate of Analysis should contain four blocks. If a supplier file is missing any of them, ask for it before you approve a sample – so you are not evaluating a different grade than you intend to buy.

1. Identity: Botanical verification (macroscopic / microscopic and/or HPTLC fingerprint as scoped)
2. Potency: TBA by HPLC or a validated titration method, depending on the specification; AKBA by an HPLC-based method where specified
3. Safety: Heavy metals (Pb, Cd, As, Hg), microbiology (TAMC, yeast and mold, E. coli, Salmonella), pesticides and residual solvents as scoped
4. Physical: Appearance, moisture, particle size, bulk density as specified

Sample and COA should match the commercial spec you intend to buy.

Request a Sample COA

Approving a raw-material specification is step one. These are the manufacturing risks that decide whether your SKU can run at scale and stay in spec – so they belong in the sample plan, not on the commercial line.

Powder flow and fill weight

Some concentrated TBA or AKBA extracts can present flow or fill-weight challenges, depending on assay level, carrier, particle size, and processing history. Depending on the powder characteristics, formulation may require flow aids, granulation, or other process adjustments to maintain consistent filling and compression. We validate flow and fill during sample development.

Taste and odor

Boswellia extracts are bitter and aromatic. Capsules isolate that for you. Gummies, chewables, flavored powders, and sachets do not. Taste masking adds excipient load and sample time – budget it if the format is open.

Ingredient compatibility

Moisture, pack, and dating

Some Boswellia extracts are moisture-sensitive or hygroscopic, depending on grade and carrier. Packaging is evaluated against extract characteristics, finished formula, target shelf life, and storage conditions. Desiccants or higher-barrier packaging may be appropriate for some projects. A stability protocol is scoped when dating is claimed. Raw-material shelf life does not establish finished-product dating.

Non-capsule formats add sensory and stability work to your sample plan. Capsules with agreed barrier pack remain the lowest-risk path to a dated SKU.

Process work: Processing Technologies.

The purpose of testing is not to make the COA longer. It is to verify that the material you approved is the material released into your finished SKU – and that the next batch can be released against the same file.

The test plan follows the agreed specification – not a default “run every method on every lot.” The commercial batch is released against the same approved specification used for the sample.

Incoming Boswellia material

Released against the project file before weighing: botanical identity (B. serrata); oleogum resin as plant part; TBA or AKBA specification and method when the grade is standardized; moisture; microbiology; heavy metals; pesticides and residual solvents as specified; supplier documentation (COA, allergen, origin as scoped).

If the COA marker, method, or grade does not match the BOM, the lot is not released.

Incoming material is released against the approved supplier documentation and project specification.

Checks during blending and fill

Blend uniformity on validated processes; fill weight or tablet weight; compression or capsule parameters; moisture where relevant; disintegration where the format requires it.

Finished SKU before release

Identity; assay vs the agreed finished-product specification (TBA and/or AKBA and any other declared actives); microbiology; heavy metals as scoped; physical specifications; packaging integrity as scoped.

Batch documentation you can file

Per batch, as scoped: Certificate of Analysis, specification sheet, SDS, allergen statement, and Halal / Kosher / organic files when the project requires them. Retention samples follow the quality agreement.

Lab: in-house release; SGS or Eurofins when the RFQ requires a third-party pack. Limits follow the approved spec and destination market. Methods: Quality Control.

Manufacturing evidence (operating proof, not the product story): 19+ years | 500+ brand projects | multi-market OEM. Capacity, certificates, and quality-system detail sit on the linked pages above.

Compliance depends on formula + dose + population + claim language + market, not on Boswellia as a category. Aligning copy before artwork saves a rejected label cycle. This page is not legal approval.

For U.S. dietary supplements, structure/function claims may be possible when they are substantiated, carry the required disclaimer, and meet applicable FDA requirements. Claim directions used in this category include joint comfort, mobility and flexibility, and traditional joint-health positioning. They are not pre-cleared statements, and they are not disease claims.

U.S. structure/function claims are not disease claims. Where they are used, they require substantiation, the required FDA disclaimer, and the applicable notification process. Other markets have their own claim lists and classification rules.

We manufacture to the agreed specification and support Supplement Facts / local information-panel layout. We do not write marketing copy or medical claims. Final label language is reviewed for the target market before artwork approval. Brand owners confirm copy with qualified counsel.

MOQ and lead time depend on dosage form, formula complexity, packaging, testing, material availability, and production scheduling. A bulk extract order and a finished gummy SKU should not use the same MOQ logic – comparing them will make the first PO look cheaper than it can be manufactured.

Manufacturing capacity is site-level; actual project allocation depends on dosage form, formula, packaging, production scheduling, and current load. See our Manufacturing Capacity page for site-level figures. Boswellia gummies remain project-scoped even though gummy lines exist.

How long sample, pilot, and mass production usually take

Indicative. Confirmed after formula, availability, pack, and testing are reviewed.

Library formulas (F01-F07) or an equivalent locked BOM, with in-stock inputs and specified pack, move faster than a new flavored gummy. That is usually the shortest path if you need a first shipment date you can plan against.

Why your MOQ is not one number

Actual MOQ and lead time depend on formula complexity, packaging, testing requirements, and production schedule.

Do not compare a bulk-ingredient kilogram MOQ with a finished retail SKU MOQ. They are different production stages. Bulk extract and finished-product OEM are separate procurement paths: the former is priced by material grade and lot size; the latter adds formulation, dosage form, packaging, testing, and production requirements. That is why a bulk extract lot and a 5,000-unit capsule run are not one MOQ.

HDPE / PET bottles with induction seals | blisters | foil bags | stick multipacks | retail cartons | export master cases | desiccant and tamper-evident finishes as scoped. Pack type is part of moisture and dating control, not a late artwork decision.

Get a Project-Specific MOQ and Lead-Time Estimate